Księgarnia naukowa
English Polski
On-line access

News

0.00 PLN
Bookshelf (0) 
Your bookshelf is empty
Free access during pandemic


Elsevier offers free access to unique set of biomedical research tools & content for researchers working on coronavirus
2020-04-30

COVID_19_OFFER_ENElsevier, a global leader in information analytics specialising in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and life science companies accelerate efforts to address the current pandemic.

The new Elsevier Coronavirus Research Hub currently includes a biomedical database, scientific and clinical content, COVID-19-specific datasets, a biomedically-focused text mining solution and several research collaboration tools, with more tools coming soon.

The Hub currently includes free access to Embase, ClinicalKey, Mendeley, Mendeley Data, the Pure COVID-19 Research Collaboration Center, SSRN and Elsevier Text Mining (MedScan). Access to other Elsevier solutions including Pathway Studio, Reaxys and Reaxys Medicinal Chemistry and Veridata EDC (Electronic Data Capture) is coming soon. Access is available through October 28, 2020.

The Coronavirus Research Hub is Elsevier’s latest contribution to help researchers and clinicians during this global emergency. In addition, Elsevier’s Novel Coronavirus Information Center provides the newest expert, curated information for the research and health communities on Novel Coronavirus (also referred to as COVID-19 and its temporary title 2019-nCoV). The Information Center also includes a link to Elsevier’s ScienceDirect, where more than 21,000 research articles relevant to Coronavirus, SARS, and MERS are freely available. For the healthcare community, the Elsevier COVID-19 Healthcare Hub provides clinicians and patients free access to toolkits, expert insights, research resources and COVID-19 guidelines as well as FAQs on symptoms.

Strony www Białystok Warszawa
801 777 223